|   | UTHR | United Therapeutics Corp | 
| Pharmaceutical Preparations | 
| Book value per $ invested | $ 0.31 | 
| Leverage | 10.35% | 
| Market Cap | $ 21.4B | 
| PE | 16.90 | 
| Dividend Yield | 0.00% | 
| Profit | $ 1.3B | 
| Margin | 40.66% | 
United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company is headquartered in Silver Spring, Maryland.